Direct PeptidesProduct page includes use or preparation wordingIn stock
Ipamorelin · 10 mg × 10 vials
$709.00$7.09 / mg
Checked · 5 days ago
Lab report: Not linked
View product details (opens in a new tab)No commercial relationship
Research listings · Peptides
Ipamorelin research listings: prices and suppliers
Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.
We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.
Prices observed weekly · last check · How we check prices →
Lowest current at 10 mg × 10 vials$7.09 / mg · $709.00Direct Peptides · checked 5 days ago
Listings at 10 mg × 10 vials
| Supplier link | |||||||
|---|---|---|---|---|---|---|---|
| Direct PeptidesProduct page includes use or preparation wording | 10 mg × 10 vials | $709.00 | $7.09 / mg | In stock | 5 d ago | Not linked | View product details (opens in a new tab)No commercial relationship |
- Prices exclude shipping. A matching name does not verify the contents of a lot.
- Lab reports are vendor-reported, not independently authenticated. “Lab confirmed” means the issuing laboratory confirmed the report is theirs.
- Some suppliers’ product pages include use or preparation wording. We list their prices for comparison only; we do not endorse that wording, and nothing on this site is guidance on preparing or using these materials.
By size
Every package size we track for Ipamorelin. Current means seen in the last 8 days.
| 2 mg × 1 vial | $17.56 | $8.78 / mg | 1 / 1 | 1 |
|---|---|---|---|---|
| 5 mg × 1 vial | $24.65 | $4.93 / mg | 8 / 9 | 8 |
| 10 mg × 1 vial | $32.63 | $3.26 / mg | 7 / 7 | 7 |
| 5 mg × 10 vials | $232.00 | $4.64 / mg | 1 / 1 | 1 |
| 10 mg × 10 vials | $709.00 | $7.09 / mg | 1 / 1 | 1 |
Research context
From our own records, with the date each was last checked.
- FDA approval
- No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
- 503A / 503B compounding
- 503A nominations withdrawn; ipamorelin acetate is in 503B category 2 (significant safety risks) since 2023-09-29Checked
- Advisory committee (PCAC)
- PCAC voted 0 yes, 12 no, 1 abstention on placing ipamorelin free base, and the same on ipamorelin acetate, on the 503A listChecked
- Rulemaking / enforcement
- No proposed or final rule found in the Federal Register (search on 2026-11-03); the only FDA match is the 2024 PCAC meeting noticeChecked
- WADA
- S2.2.4 Growth hormone releasing factors: growth hormone secretagogues (GHS) · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
- Human studies
- 1 recorded
- Identity
- Formula C38H49N9O5 · MW 711.9 g/mol · CAS 170851-70-4Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2Source record Checked
Read the guide:CJC-1295 and Ipamorelin: Reading the Research Separately
How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.